ADP-ribosylation factor (ARF) Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts the function of the guanine nucleotide exchange factor (GEF) for ARF, inhibiting ARF activation. This leads to the prevention of vesicle formation and trafficking, impacting cellular processes dependent on ARF-mediated vesicular transport. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
Specifically inhibits ARF activation on the Golgi apparatus. By disrupting the ARF-GTP cycle, Golgicide A interferes with vesicle formation and trafficking at the Golgi, affecting intracellular transport processes associated with ARF activity. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $273.00 | 6 | |
Blocks the activity of the ARF guanine nucleotide exchange factor (ARF GEF), inhibiting ARF activation. This inhibition disrupts the normal functioning of ARF in vesicle formation and trafficking, impacting cellular processes reliant on ARF-mediated intracellular transport. | ||||||
Exo2 | 304684-77-3 | sc-215011 sc-215011A | 5 mg 25 mg | $87.00 $282.00 | 1 | |
Inhibits ARF activation by targeting the ARF guanine nucleotide exchange factor (ARF GEF). By disrupting the ARF-GTP cycle, Exo2 interferes with vesicle formation and trafficking, influencing cellular processes dependent on ARF-mediated intracellular transport. | ||||||
Wnt Synergist, QS11 | 944328-88-5 | sc-222417 sc-222417A | 5 mg 25 mg | $138.00 $595.00 | ||
Inhibits ARF activation by disrupting the function of the ARF guanine nucleotide exchange factor (ARF GEF). This interference with the ARF-GTP cycle impacts vesicle formation and trafficking, affecting cellular processes reliant on ARF-mediated intracellular transport. | ||||||